Cargando…
NF-E2-related factor 2 over-expression in mesenchymal stem cells to improve cellular cardiomyoplasty
Myocardial infarction (MI) is the leading cause of death worldwide. Various therapeutic strategies have been introduced for MI treatment. In recent years, interest in utilizing mesenchymal stem cells (MSCs) for MI therapy has increased. In fact, the use of MSCs for MI treatment, known as cellular ca...
Autores principales: | Mohammadzadeh-Vardin, Mohammad, Roudkenar, Mehryar Habibi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Electronic physician
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324274/ https://www.ncbi.nlm.nih.gov/pubmed/25763150 http://dx.doi.org/10.14661/2014.808-813 |
Ejemplares similares
-
Nuclear factor erythroid-2 related factor 2 overexpressed mesenchymal stem cells transplantation, improves renal function, decreases injuries markers and increases repair markers in glycerol-induced Acute kidney injury rats
por: Zhaleh, Fateme, et al.
Publicado: (2016) -
Cellular Cardiomyoplasty and Cardiac Regeneration
por: Pendyala, Lakshmana, et al.
Publicado: (2008) -
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
por: Taylor, Doris A
Publicado: (2001) -
New Approaches in Heart Research: Prevention Instead of Cardiomyoplasty?
por: Gaebel, Ralf, et al.
Publicado: (2023) -
Taming of Covid-19: potential and emerging application of mesenchymal stem cells
por: Najafi-Ghalehlou, Nima, et al.
Publicado: (2021)